Adriatic
Argentina
Asia-Pacific
Australia and New Zealand
Bangladesh
Belgique (Belgium)
België (Belgium)
Brasil (Brazil)
Bulgaria
Canada
Canada
Central/Eastern Europe, Middle East & Africa
Česká republika (Czech Republic)
Chile
中国 (China)
Colombia
Costa Rica
Србија (Serbia)
Danmark (Denmark)
Deutschland (Germany)
Ecuador
España (Spain)
Europe
France
Ελλάδα (Greece)
香港特區 (Hong Kong SAR)
Indian Subcontinent
Ireland
Israel ישראל
Italia (Italy)
日本 (Japan)
Latinoamérica
Magyarország (Hungary)
México (Mexico)
Nederland (Netherlands)
Norge (Norway)
Österreich (Austria)
Panama
Paraguay
Perú (Peru)
Philippines
Polska (Poland)
Российская Федерация (Russia)
Portugal
Puerto Rico
Romania
العربية الشرق Middle East
Schweiz (Switzerland)
Slovenská republika (Slovak Republic)
South Africa and Sub-Sahara
대한민국 (South Korea)
Suisse (Switzerland)
Suomi (Finland)
Sverige (Sweden)
台灣地區 (Taiwan)
ประเทศไทย (Thailand)
Türkiye (Turkey)
United Kingdom
United States
Uruguay
Україна (Ukraine)
Tiếng Việt (Vietnam)
We’re committed to partnerships with interventional radiologists, pathologists, oncologists, surgeons, and the GI community for proactive GI care.
| FEATURED PRODUCT |
ACHIEVE MORE WITH EUS
Three interchangeable needles — the FNA, FNB, and FNF — allow for predictable biliary access, fine needle aspiration, fine needle biopsy, fiducial placement and improved procedural workflow in one procedure. 1-8
- The six distal cutting edges of the SharkCore™ FNB needle are specifically designed to obtain cohesive units of tissue with intact cell architecture.9-11
- The Beacon™ FNA needle, an interchangeable component of the Beacon™ EUS delivery system, is designed to improve tissue yield.1,12-13
- The Beacon™ FNF needle, pre-loaded with two solid gold markers, helps simplify the procedure, and reduces overall procedure time.14
PRESERVE THEIR FUTURE
Successful management of non-resectable liver tumors is about more than what you remove — it’s about what you leave behind, too.
The Emprint™ ablation system supports your journey from careful planning to predictable success when treating small to medium sized liver malignancies alone or with surgery. It enables a minimally invasive procedure with:
- Few side-effects15
- Fast recovery time16
This technology demonstrates controllable and
predictable ablation zones and single digit local recurrence
rates clinically.15,17-19
Barrx™
Radiofrequency Ablation System
The Barrx™ radiofrequency ablation system includes technology for treating Barrett's esophagus.20
MEDICAL
EDUCATION & RESOURCES
We are committed to delivering educational solutions and resources aimed at helping you achieve procedural and clinical proficiency.
LEARN MORE
FOLLOW US ON
LinkedIn
Stay up to date with new products, innovative stories, and events.
Connect with us:
1
TR110601 Rev 01 DV Report Dated November 11, 2011 (Data on file)
2
PPQ Report: TR-20009 Rev 01 dated March 9, 2015 (Data on File)
3
AA study report: TR-20003 Rev 01 dated March 18, 2015 (Data on file)
4
510k study TR100509 Rev 01 dated September 21, 2010 (Data on file).
5
AA study TR100706 Rev 01 dated January 6, 2011 (Data on file).
6
AA study TR110716 Rev 01 dated December 16, 2011 (Data on file).
7
DV/PPQ report: TR110601 Rev 01 dated November 11, 2011 (Data on file).
8
Based on internal testing data,V-0450-02 (Access DVT Report) dated February 8, 2019 (Data on file).
9
Internal test report #1085, July 8, 2014 and Internal test report #1090, September 25, 2014 (Data on file).
10
DiMaio CJ, Kolb JM, Benias PC, et al. Initial experience with a novel EUS-guided core biopsy needle (SharkCore™): results of a large North American multicenter study. Endosc Int Open. 2016;4(9):E974–E979.
11
Jovani M, Abidi WM, Lee LS. Novel fork-tip needles versus standard needles for EUS-guided tissue acquisition from solid masses of the upper GI tract: a matched cohort study. Scand J Gastroenterol. 2017;52(6–7):784–787.
12
Enestvedt B, Maranki, J, Makipour K, Mathur M, Haluszka O. Is two betterthan one? A comparison of EUS-FNA efficiency of single-vs multi-needle platforms. Gastrointest Endosc. 2013;77(5S):AB179.
13
Moore JZ, Zhang Q, McGill CS, et al. Modeling of the plane needle cutting edge rake and inclination angles for biopsy. J Manuf Sci Eng 2010;132:051005-1-051005-8.22b.
14
Kothari S, Kothari T, et al. 234, Endoscopic Ultrasound (EUS)-Guided Fiducial Placement for Stereotactic Body Radiotherapy (SBRT): First Global Experience with a New 22-Gauge “Pre-loaded” EUS Fiducial Needle The American Journal of Gastroenterology, vol 110, Supplement 1 October 2015
15
De Cobelli F et al. microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol(2017)34:49
16
Takahashi H et al. Local Recurrence After Laparoscopic Radiofrequency Ablation of Malignant Liver Tumors: Results of a Contemporary Series. Surgery. 2017 doi: 10.1016/j.surg.2017.10.026.
17
Vogl et al. (2017). Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. International Journal of Hyperthermia, DOI: 10.1080/02656736.2017.1358408.
18
Imajo K. et al. New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones. J Gastroenterol Hepatol. 2018;33(12):2007-2014.
19
Vogl, TJ., Basten, LM., Nour-Eldin, A., Kaltenbach, B., Bodelle, B., Wichmann, JL., Ackermann, H., Naguib, NNN. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zones. Int J Hyperthermia. 2018 Jun;34(4):492-500.
20
Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867-876.